Navigation Links
Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology
Date:6/22/2011

LITTLETON, Mass., June 22, 2011 /PRNewswire/ -- Still River Systems, Inc. announces today that it has entered into a long-term licensing agreement with the Massachusetts Institute of Technology (M.I.T.) to utilize advanced superconducting accelerator technologies developed at M.I.T.'s Plasma Science and Fusion Center in collaboration with Still River.  Still River will employ those technologies in conjunction with its own leading-edge developments in its groundbreaking single-room proton therapy platform, the Monarch250. This unique medical device houses a revolutionary source of high-energy protons based on the world's highest field strength superconducting synchrocyclotron that provides a significant reduction in the size, cost, and complexity of developing and operating a proton therapy center.

The precision of proton therapy makes it an important treatment option for patients with cancer. Protons can be directed to concentrate their energy precisely on the cancerous tumor while sparing the surrounding healthy tissue, resulting in far fewer short and long-term treatment complications. The first Monarch250 is currently under installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO, a National Cancer Institute (NCI) Comprehensive Cancer Center.

The proton accelerator has been undergoing complete clinical testing and commissioning, including lifetime testing, and all clinical parameters have exceeded performance expectations. "The innovative design of our proton therapy platform, aided by the technology developed with M.I.T., results in a simple and modular system thus enabling quick, efficient, and cost effective installations," states CEO Joseph Jachinowski. "With our first system nearing completion, we are now beginning to reap the benefits of its unique design by finalizing a complete process that can be replicated to meet the growing proton therapy demand in a cost-efficient manner."

Still River Systems will be exhibiting at the Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Vancouver, British Columbia on July 31st through August 3rd.  

ABOUT STILL RIVER SYSTEMS

Still River Systems, Inc., based in Littleton, Massachusetts, is dedicated to providing physicians, and their patients, access to high quality, cost-effective proton therapy solutions. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment.

The Monarch250 has not been cleared by the US Food and Drug Administration for distribution or clinical use. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit www.stillriversystems.com


'/>"/>
SOURCE Still River Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
2. Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases
3. Report: Inappropriate Antibiotic Use Still High Despite Educational Efforts
4. Video and Stills from Bill & Melinda Gates Foundation Available on thenewsmarket.com: UK Government and Bill & Melinda Gates Foundation Announce New Commitment to Eradicating Polio
5. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
6. Still River Systems Announces Production Milestone for the Worlds Smallest High-Energy Proton Therapy Accelerator
7. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
8. First Perry Baromedical Sigma Elite Hyperbaric Chamber with EMR Installed at Stillwater Medical Center
9. Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public
10. Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available
11. U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
Breaking Medicine News(10 mins):